CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SUPN

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
SUPNPhase 2

SPN-821 2400 mg Phase 2 Est. Readout

SPN-821 2400 mg
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Major Depressive Disorder (MDD)

View Full Landscape
Drug Information

Target Indication

Major Depressive Disorder (MDD)

Clinical Trial

NCT07226661

Last updated: 3/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.